| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 416 | 2010 |
| Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007 | 376 | 2007 |
| Clinical characterization of familial isolated pituitary adenomas AF Daly, ML Jaffrain-Rea, A Ciccarelli, H Valdes-Socin, V Rohmer, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3316-3323, 2006 | 297 | 2006 |
| Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database P Petrossians, AF Daly, E Natchev, L Maione, K Blijdorp, ... Endocrine-related cancer 24 (10), 505-518, 2017 | 286 | 2017 |
| Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients L Vroonen, ML Jaffrain-Rea, P Petrossians, G Tamagno, P Chanson, ... European journal of endocrinology 167 (5), 651-662, 2012 | 216 | 2012 |
| Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients L Rostomyan, AF Daly, P Petrossians, E Nachev, AR Lila, AL Lecoq, ... Endocrine-related cancer 22 (5), 745-757, 2015 | 206 | 2015 |
| X-linked acrogigantism syndrome: clinical profile and therapeutic responses A Beckers, MB Lodish, G Trivellin, L Rostomyan, M Lee, FR Faucz, ... Endocrine-related cancer 22 (3), 353-367, 2015 | 195 | 2015 |
| How to classify pituitary neuroendocrine tumors (PitNET) s in 2020 J Trouillas, ML Jaffrain-Rea, A Vasiljevic, G Raverot, F Roncaroli, C Villa Cancers 12 (2), 514, 2020 | 188 | 2020 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, ... European journal of endocrinology 165 (4), 509-515, 2011 | 186 | 2011 |
| Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism E Ferretti, L Persani, ML Jaffrain-Rea, S Giambona, G Tamburrano, ... The Journal of Clinical Endocrinology & Metabolism 84 (3), 924-929, 1999 | 183 | 1999 |
| The long‐term efficacy of conventional radiotherapy in patients with GH‐secreting pituitary adenomas G Minniti, ML Jaffrain‐Rea, M Osti, V Esposito, A Santoro, F Solda, ... Clinical endocrinology 62 (2), 210-216, 2005 | 176 | 2005 |
| Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications ML Jaffrain-Rea, M Angelini, D Gargano, MA Tichomirowa, AF Daly, ... Endocrine-related cancer 16 (3), 1029-1043, 2009 | 170 | 2009 |
| Mutations in the Aryl Hydrocarbon Receptor Interacting Protein Gene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas A Barlier, JF Vanbellinghen, AF Daly, M Silvy, ML Jaffrain-Rea, J Trouillas, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1952-1955, 2007 | 165 | 2007 |
| A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. ML Jaffrain-Rea, D Di Stefano, G Minniti, V Esposito, A Bultrini, E Ferretti, ... Endocrine-Related Cancer 9 (2), 103-113, 2002 | 151 | 2002 |
| Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) R Baldelli, A Colao, P Razzore, ML Jaffrain-Rea, P Marzullo, E Ciccarelli, ... The Journal of Clinical Endocrinology & Metabolism 85 (11), 4099-4103, 2000 | 149 | 2000 |
| Long-term follow-up results of postoperative radiation therapy for Cushing’s disease G Minniti, M Osti, ML Jaffrain-Rea, V Esposito, G Cantore, R Maurizi Enrici Journal of neuro-oncology 84, 79-84, 2007 | 133 | 2007 |
| Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells M Theodoropoulou, T Arzberger, Y Gruebler, ML Jaffrain-Rea, J Schlegel, ... Journal of Endocrinology 183 (2), 385-394, 2004 | 131 | 2004 |
| Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature G Minniti, V Esposito, M Piccirilli, A Fratticci, A Santoro, ML Jaffrain-Rea European journal of endocrinology 153 (6), 723-735, 2005 | 124 | 2005 |
| The genetics of pituitary adenomas S Vandeva, ML Jaffrain-Rea, AF Daly, M Tichomirowa, S Zacharieva, ... Best Practice & Research Clinical Endocrinology & Metabolism 24 (3), 461-476, 2010 | 122 | 2010 |
| T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly. I Potorac, P Petrossians, A Daly, O Alexopoulou, S Borot, ... Endocrine-Related Cancer 23 (11), 2016 | 121 | 2016 |
